Top broker downgrades Santos share price to underperform

Santos Ltd (ASX: STO): Buy, hold, sell?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

a woman

The News Corp press is reporting that oil and LNG giant Santos Ltd (ASX: STO) has been downgraded to underperform by top broker Credit Suisse after its share price gained 17% in the past year and 84% over the past two years.

Driving Santos' success has been rising oil and energy prices alongside management being able to fix a balance sheet that was previously drowning in debt.

For the full year ending December 31 2019 Santos posted a record underlying profit of US$727 million on revenue of US$3,660 million with US$9.7 cents per share paid to shareholders out over the year.

It also completed the US$2.15 billion purchase of Quadrant Energy Ltd from capital markets wheeler and dealer Macquarie Group Ltd (ASX: MQG).

Net debt has also been reduced to US$3,559 million, which is high, but not compared to the US$6,128 million level of 2014 that came about due to the decision to invest eye-watering amounts of capital into developing its Gladstone LNG project prior to energy prices tumbling in 2015.

Santos looks a turnaround story assuming oil prices remain elevated and its balance sheet focus is retained.

However, I'm not a buyer of Santos shares for a number of reasons and would tend to agree with Credit Suisse's verdict on it from here.

Motley Fool contributor Tom Richardson owns shares of Macquarie Group Limited. You can find Tom on Twitter @tommyr345 The Motley Fool Australia has recommended Macquarie Group Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Three children wearing athletic short and singlets stand side by side on a running track wearing medals around their necks and standing with their hands on their hips.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a rough start to the trading week this Monday.

Read more »

A man looking at his laptop and thinking.
Broker Notes

Forget CBA shares and buy this ASX ETF: experts

Here's what experts are saying about these two investment options.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

Buy, hold, sell: BHP, Guzman Y Gomez, and Pro Medicus shares

Are brokers bullish or bearish on these names? Let's find out.

Read more »

Red buy button on an Apple keyboard with a finger on it.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to buy these shares.

Read more »

Humanoid robot analysing the stock market, symbolising artificial intelligence shares.
Broker Notes

Up 109% since November, are Appen shares still a buy today?

A leading expert digs into the outlook for Appen shares amid the rise of AI.

Read more »

Paper aeroplane going down on a chart, symbolising a falling share price.
Travel Shares

Why Web Travel shares are sliding as fresh takeover hopes return

Web Travel shares sink as investors weigh CEO succession and takeover risk.

Read more »

Shot of a young businesswoman looking stressed out while working in an office.
Share Fallers

Why 4DMedical, Brainchip, Catapult, and Star Entertainment shares are falling today

These shares are starting the week in the red. But why>

Read more »

A white and black clock face is shown with three hands saying Time to Buy reflecting Citi's view that it's time to buy ASX 200 banks
Broker Notes

3 reasons to buy Pro Medicus shares today

Two leading investment analysts believe Pro Medicus shares are primed for a rebound.

Read more »